Fundraising Fox
Josh Silverman
InvestorCEO and Founder of Windfall Bio at Baruch Future Ventures
Sunnyvale, California, United States
Find your path to Josh
860 people in our graph can introduce you to Josh.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Nicholas Brathwaite to introduce you to Josh
You →Nicholas · together at Calysta Energy (2015–2018) →Josh
Ask Jamie Chen to introduce you to Josh
You →Jamie · 2 people · together at Maxygen →Josh
Ask Sam Okafor to introduce you to Josh
You →Sam · together at Siluria Technologies, Inc. →Josh
Sign up to find every way you can get introduced to Josh
- Your email: the people you already email who know Josh
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Josh
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Josh Silverman, Ph.D., is the CEO and founder of Windfall Bio, which develops nature-based technology to convert methane into organic soil nutrients. He has more than 20 years of experience in biotech research and commercialization, previously serving as CEO of Aromyx, founder and CTO of Calysta, and VP of Drug Development at Amunix, and has advised several climate-focused biotech companies. He holds a B.Sc. in Molecular Biology from UC San Diego and a Ph.D. in Biochemistry from Stanford University.
Invests in
BiotechCleantechClimate Tech
Experience
- Windfall BioChief Executive Officer & Foundercurrent2022 — presentMenlo Park, California, United States
- Aromyx CorporationChief Science Advisorcurrent2022 — present
- Aromyx CorporationCEO2018 — 2022
- Calysta EnergyChief Technology Officer and Co-Founder2011 — 2018
- S3 Innovations, IncPresident and Founder2010 — 2014
- Siluria Technologies, Inc.Scientific founder and phage supplier2008 — 2012South San Francisco, California, United States
- Amunix, Inc.Vice President, Product Development2008 — 2011
- AmgenDirector Process Development2006 — 2008
- Avidia Research InstituteDirector - CMC2003 — 2006
- MaxygenScientist2002 — 2003
Skills & more
+4 more
CellBiomarkersAssay DevelopmentProtein PurificationFrom Josh's professional profile.
Investments
Investor
AmborasCommon RoomGustoOwnzaSidecarSiteAware
Per curated public sources.
Colleagues at Baruch Future Ventures
Frequently asked questions
- Who is Josh Silverman?
- Josh Silverman, Ph.D., is the CEO and founder of Windfall Bio, which develops nature-based technology to convert methane into organic soil nutrients. He has more than 20 years of experience in biotech research and commercialization, previously serving as CEO of Aromyx, founder and CTO of Calysta, and VP of Drug Development at Amunix, and has advised several climate-focused biotech companies. He holds a B.Sc. in Molecular Biology from UC San Diego and a Ph.D. in Biochemistry from Stanford University.
- Where does Josh Silverman work?
- Josh Silverman is CEO and Founder of Windfall Bio at Baruch Future Ventures.
- What does Josh Silverman invest in?
- Josh Silverman invests in Biotech, Cleantech, Climate Tech.
- What companies has Josh Silverman invested in?
- Investments tracked here include Amboras, Common Room, Gusto, Ownza, Sidecar, SiteAware.
- Where did Josh Silverman go to school?
- Josh Silverman studied at Stanford University School of Medicine (Doctor of Philosophy (PhD), Biochemistry); Stanford University (PhD, Biochemistry).
Founder mafias
Stanford University mafia2,240
Also came through, then founded or led a company.
Stanford University School of Medicine mafia87
Also came through, then founded or led a company.
Baruch Future Ventures mafia4
Also came through, then founded or led a company.
Same school
Also attended Stanford University School of Medicine171
+ 165 more
Also attended Stanford University2,000
+ 1,994 more
